Hussman Strategic Advisors, Inc. Exact Sciences Corp Transaction History

Hussman Strategic Advisors, Inc.

$386 Million
Q3 2024

A detailed history of Hussman Strategic Advisors, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 16,800 shares of EXAS stock, worth $1.02 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

16,800

Previous 42,000 60.0%

Holding current value

$1.02 Million

Previous $1.77 Million 35.57%

% of portfolio

0.3%

Previous 0.51%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$42.43 - $70.83 $1.07 Million - $1.78 Million	-25,200 Reduced 60.0%	16,800 $1.14 Million
Q1 2024 May 01, 2024	BUY	$56.27 - $73.77 $590,835 - $774,585	10,500 Added 33.33%	42,000 $2.9 Million
Q4 2023 Feb 01, 2024	BUY	$59.06 - $75.72 $1.49 Million - $1.91 Million	25,200 Added 400.0%	31,500 $2.33 Million
Q3 2023 Nov 07, 2023	BUY	$65.94 - $99.04 $415,422 - $623,952	6,300 New	6,300 $429,000
Q2 2022 Sep 12, 2022	SELL	$35.61 - $76.23 $277,758 - $594,594	-7,800 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$72.5 - $100.68 $108,750 - $151,020	-1,500 Reduced 16.13%	7,800 $607,000
Q3 2021 Nov 01, 2021	SELL	$90.24 - $124.05 $279,744 - $384,555	-3,100 Reduced 25.0%	9,300 $888,000
Q2 2021 Aug 03, 2021	BUY	$93.66 - $139.27 $824,208 - $1.23 Million	8,800 Added 244.44%	12,400 $1.54 Million
Q1 2021 May 03, 2021	BUY	$116.57 - $155.01 $419,652 - $558,036	3,600 New	3,600 $474,000
Q3 2020 Nov 02, 2020	SELL	$72.92 - $102.01 $729,200 - $1.02 Million	-10,000 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$55.75 - $92.75 $836,250 - $1.39 Million	-15,000 Reduced 60.0%	10,000 $869,000
Q1 2020 May 01, 2020	BUY	$37.9 - $104.44 $568,500 - $1.57 Million	15,000 Added 150.0%	25,000 $1.45 Million
Q4 2019 Jan 31, 2020	BUY	$77.66 - $99.74 $776,600 - $997,400	10,000 New	10,000 $925,000
Q2 2019 Jul 31, 2019	SELL	$89.51 - $118.04 $895,100 - $1.18 Million	-10,000 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$61.98 - $96.5 $309,900 - $482,500	-5,000 Reduced 33.33%	10,000 $866,000
Q4 2018 Feb 01, 2019	SELL	$56.04 - $82.66 $280,200 - $413,300	-5,000 Reduced 25.0%	15,000 $946,000
Q3 2018 Oct 31, 2018	SELL	$48.29 - $80.6 $241,450 - $403,000	-5,000 Reduced 20.0%	20,000 $1.58 Million
Q2 2018 Jul 31, 2018	SELL	$37.84 - $69.96 $1.89 Million - $3.5 Million	-50,000 Reduced 66.67%	25,000 $1.5 Million
Q1 2018 May 01, 2018	BUY	$39.82 - $57.53 $2.99 Million - $4.31 Million	75,000 New	75,000 $3.03 Million

Others Institutions Holding EXAS

# of Institutions

674

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.7B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.

Account

Hussman Strategic Advisors, Inc. Exact Sciences Corp Transaction History